Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M308938200 on December 1, 2003

J. Biol. Chem., Vol. 279, Issue 8, 6737-6745, February 20, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/8/6737    most recent
M308938200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trisciuoglio, D.
Right arrow Articles by Del Bufalo, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trisciuoglio, D.
Right arrow Articles by Del Bufalo, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

bcl-2 Induction of Urokinase Plasminogen Activator Receptor Expression in Human Cancer Cells through Sp1 Activation

INVOLVEMENT OF ERK1/ERK2 ACTIVITY*

Daniela Trisciuoglio{ddagger}§, Angela Iervolino{ddagger}§, Antonio Candiloro{ddagger}, Gabriella Fibbi||, Maurizio Fanciulli**, Uwe Zangemeister-Wittke{ddagger}{ddagger}, Gabriella Zupi{ddagger}, and Donatella Del Bufalo{ddagger}§§

From the {ddagger}Experimental Chemotherapy Laboratory and **Laboratory B, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158 Rome, Italy, the ||Department of Pathology and Oncology, University of Florence, 50134 Florence, Italy, and the {ddagger}{ddagger}Department of Oncology, University Hospital Zurich, Zurich 8044, Switzerland

We have previously demonstrated that Bcl-2 overexpression in human breast carcinoma and melanoma cells synergizes with hypoxia to increase angiogenesis through up-regulation of vascular endothelial growth factor. In this work we demonstrated, for the first time, that Bcl-2 overexpression in cancer cells exposed to hypoxia modulates urokinase plasminogen activator receptor (uPAR) expression through Sp1 transcription factor and that the extracellular signal-regulated kinase (ERK) pathway plays a role in Sp1 transcriptional activity. In particular, an increase in uPAR protein and mRNA expression was found in melanoma bcl-2 transfectants grown under hypoxia when compared with control cells, and a decrease of uPAR protein expression was induced by treatment of cells with specific bcl-2 antisense oligonucleotides. Up-regulation of uPAR expression was accompanied by increased Sp1 protein expression, stability, serine phosphorylation, and DNA binding activity. Treatment of cells with mitramycin A, an inhibitor of Sp1 activity, confirmed the role of Sp1 transcriptional activity in uPAR induction by Bcl-2. The contribution of the ERK pathway in Sp1-increased transcriptional activity was demonstrated by the use of chemical inhibition. In fact, ERK kinase activation was induced in Bcl-2-overexpressing cells exposed to hypoxia, and the ERK kinase inhibitor UO126 was able to down-regulate Sp1 phosphorylation and DNA binding activity. Using a human breast carcinoma line, we obtained data supporting our findings with melanoma cells and identified a link between the induction of Sp1 and uPAR expression as a common bcl-2-controlled phenomenon in human tumors. In conclusion, our results strongly indicate that up-regulation of uPAR expression by Bcl-2 in hypoxia is modulated by Sp1 DNA binding activity through the ERK signaling pathway.


Received for publication, August 13, 2003 , and in revised form, October 14, 2003.

* This work was supported by grants from the Ministero della Sanità (to D. D. B.) and Italian Association for Cancer Research (to D. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipients of a fellowship from the Italian Foundation for Cancer Research (FIRC).

These authors contributed equally to this work.

§§ To whom correspondence should be addressed. Tel.: 39-06-52662537; Fax: 39-06-52662505; E-mail: delbufalo{at}ifo.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
K. Enya, H. Hayashi, T. Takii, N. Ohoka, S. Kanata, T. Okamoto, and K. Onozaki
The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1{alpha} in human melanoma cells
J. Leukoc. Biol., January 1, 2008; 83(1): 190 - 199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Xia, H. Wang, S. Munk, H. Frecker, H. J. Goldberg, I. G. Fantus, and C. I. Whiteside
Reactive oxygen species, PKC-beta1, and PKC-{zeta} mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1280 - E1288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Koga, I. Kuwahara, E. P. Lillehoj, W. Lu, T. Miyata, Y. Isohama, and K. C. Kim
TNF-{alpha} induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L693 - L701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. C. Marinovic, B. Zheng, W. E. Mitch, and S. R. Price
Tissue-specific regulation of ubiquitin (UbC) transcription by glucocorticoids: in vivo and in vitro analyses
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F660 - F666.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Trisciuoglio, A. Iervolino, G. Zupi, and D. Del Bufalo
Involvement of PI3K and MAPK Signaling in bcl-2-induced Vascular Endothelial Growth Factor Expression in Melanoma Cells
Mol. Biol. Cell, September 1, 2005; 16(9): 4153 - 4162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Yagi, D. McBurney, and W. E. Horton Jr.
Bcl-2 Positively Regulates Sox9-dependent Chondrocyte Gene Expression by Suppressing the MEK-ERK1/2 Signaling Pathway
J. Biol. Chem., August 26, 2005; 280(34): 30517 - 30525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao
Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas
J. Biol. Chem., June 10, 2005; 280(23): 21882 - 21892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhou, M. Callapina, G. J. Goodall, and B. Brune
Functional Integrity of Nuclear Factor {kappa}B, Phosphatidylinositol 3'-Kinase, and Mitogen-Activated Protein Kinase Signaling Allows Tumor Necrosis Factor {alpha}-Evoked Bcl-2 Expression to Provoke Internal Ribosome Entry Site-Dependent Translation of Hypoxia-Inducible Factor 1{alpha}
Cancer Res., December 15, 2004; 64(24): 9041 - 9048.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement